Fosphenytoin (injection)

فوس‌فنی‌توئین (تزریقی)

⚠ Unverified

🧠 Nervous SystemAnticonvulsant (phenytoin prodrug)

Market / country: 🇺🇸 USA

Cerebyx (US)

🧮 Dose calculator

Status epilepticus / acute repetitive seizures · Regimen source: FDA Cerebyx · 2.3FDA Cerebyx · Highlights — Dosage and Administration

  • • All doses in phenytoin sodium equivalents (PE). Rate: adults 100–150 mg PE/min (max 150); children 2 mg PE/kg/min or 150 mg PE/min, whichever is slower. Dilute to 1.5–25 mg PE/mL before infusion. Continuous ECG, BP and respiratory monitoring. Usually with an IV benzodiazepine; follow with maintenance dosing. FDA Cerebyx · 2.3FDA Cerebyx · 2.2

Enter age and weight.

🛡️ Safety & information

Contraindications

  • ⛔ Hypersensitivity to fosphenytoin, phenytoin or hydantoins; sinus bradycardia, SA block, 2nd/3rd-degree AV block, Adams-Stokes syndrome; prior phenytoin hepatotoxicity; coadministration with delavirdine. FDA Cerebyx · 4

Warnings

Formulations

  • 50 mg PE/mL (100 mg PE/2 mL; 500 mg PE/10 mL) — injection 🇺🇸 USA FDA Cerebyx · 3

👥 Special populations

  • 🤰 PregnancyUse with caution

    Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Cerebyx · 8.1

    “Risk Summary In humans, prenatal exposure to phenytoin (the active metabolite of CEREBYX) may increase the risks for congenital malformations and other adverse developmental outcomes.”
  • 🤱 BreastfeedingUse with caution

    Label: use with caution while breastfeeding; see the label text. FDA Cerebyx · 8.2

    “Following administration of phenytoin (the active metabolite of CEREBYX), phenytoin is secreted in human milk.”
  • 👶 ChildrenUse with caution

    Label: indicated in all pediatric age groups; pediatric infusion rate max 2 mg PE/kg/min or 150 mg PE/min, whichever is slower. FDA Cerebyx · 8.4

    “CEREBYX is indicated for the treatment of generalized tonic-clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery in all pediatric age groups”
  • 👴 Older adultsUse with caution

    Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Cerebyx · 8.5

    “No systematic studies in geriatric patients have been conducted.”
  • ⚥ Females & males of reproductive potentialNo data

    The source for this drug has no section for this group.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Inspired by the Saphira project; part of the content is taken from it.

Contact and correction requests — Telegram: @cenaav